Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

H9149

Sigma-Aldrich

α-Hydroxyalprazolam

powder, ≥98% (TLC)

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C17H13ClN4O
CAS Number:
37115-43-8
Molecular Weight:
324.76
MDL number:
MFCD00171226
UNSPSC Code:
12352200
PubChem Substance ID:
24895845
NACRES:
NA.77

Quality Level

200

Assay

≥98% (TLC)

form

powder

drug control

Home Office Schedule 4.1; regulated under CDSA - not available from Sigma-Aldrich Canada

color

white to off-white

solubility

methylene chloride: ~20 mg/mL, clear, colorless to faintly yellow

SMILES string

OCc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4-n12

InChI

1S/C17H13ClN4O/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)19-9-15-20-21-16(10-23)22(14)15/h1-8,23H,9-10H2

InChI key

ZURUZYHEEMDQBU-UHFFFAOYSA-N

Caution

store dessicated and protected from light

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302 + H312 + H332

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000180960
078M4118V
13140220
13170902

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R B Smith et al.
Psychopharmacology, 93(1), 105-112 (1987-01-01)
The relationships between alprazolam and metabolite concentrations and CNS effects were determined in a double-blind placebo controlled four-way crossover trial in 16 normal male volunteers. Active drug treatments consisted of 4-day regimens of 4 mg alprazolam PO daily as 2
V D Schmith et al.
Journal of clinical pharmacology, 31(6), 571-579 (1991-06-01)
In a double-blind, randomized, placebo-controlled study, the pharmacokinetics of alprazolam and its active metabolite, alpha-hydroxyalprazolam, were determined in 12 normal subjects and 12 dialysis patients [7 hemodialysis (HD) patients and 5 continuous ambulatory peritoneal dialysis (CAPD) patients]. Blood samples were
K M Höld et al.
Journal of mass spectrometry : JMS, 31(9), 1033-1038 (1996-09-01)
A sensitive and specific method was developed for the determination of alprazolam and its major metabolite alpha-hydroxyalprazolam in plasma. After the addition of deuterium-labeled internal standards, plasma samples were buffered to pH 9 with 1 ml of saturated sodium borate
D J Crouch et al.
Journal of analytical toxicology, 23(6), 479-485 (1999-10-12)
A sensitive and specific electrospray ionization high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS-MS) method has been developed for the quantitative determination of alprazolam (AL) and alpha-hydroxyalprazolam (OH-AL) in plasma. After the addition of deuterium labeled internal standards of AL and OH-AL
Agneta Wennerholm et al.
European journal of clinical pharmacology, 61(2), 113-118 (2005-04-05)
(1) To determine the pharmacokinetic parameters of alprazolam and its two metabolites in plasma from healthy volunteers; (2) to identify a suitable single time point to take a plasma sample for CYP3A phenotyping. Twelve healthy Swedish volunteers received a single
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service